跳至主要内容
临床试验/NCT03298438
NCT03298438已完成不适用

Study About Annoucement of the Diagnosis of Neurofibromatosis 1 in de Novo Forms

University Hospital, Brest1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2016年7月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
31
试验地点
1
主要终点
Study post traumatic stress disorder secondary to annoucement of diagnosis of neurofibromatosis type 1 in de novo form

研究概览

简要总结

Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant genetic disorders. The aim of our study was to evaluate post-traumatic stress disorder (PTSD) in patients and their families following the disclosure of sporadic NF1. Diagnosis of NF1 was retained according to NIH criteria, familial forms were excluded. The French version of the Impact of Event Scale-Revised was used for the diagnosis of PTSD.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient aged 18 or more, or parent of a children
  • Patient with a neurofibromatosis type 1 or parent of a children with a neurofibromatosis 1 in de novo form
  • Followed for a neurofibromatosis type 1 de novo at the dedicated consultation in the University Hospital of Brest, since april 2013
  • Agree to participate

排除标准

  • Patients aged of 18 years old or lower
  • Refusal to participate

结局指标

主要结局

Study post traumatic stress disorder secondary to annoucement of diagnosis of neurofibromatosis type 1 in de novo form

时间窗: Day 1 after diagnosis of neurofibromatosis

Questionnaire Impact of Event Scale

次要结局

  • Study methods of annoucement and feeling of patients with a questionnaire(Day 1 after diagnosis of neurofibromatosis)
  • Genetical analyze(Day 1 after diagnosis of neurofibromatosis)
  • Psychological or psychiatrical impact(Day 1 after diagnosis of neurofibromatosis)
  • Information about NF1(Day 1 after diagnosis of neurofibromatosis)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验